IL13 and systemic sclerosis: In SSc, CD4+ T-cells including follicular helper T-cells may drive autoantibody production and interactions between CD4+Th2 T-cells and fibroblasts releasing profibrotic mediators (IL-4, IL-6, IL-13) may contribute to the skin phenotype [40].